Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inamed rejects mergers and repurchases stock:

This article was originally published in Clinica

Executive Summary

Breast implant manufacturer Inamed has finished evaluating its strategic options - a process it began in early October - and plans to resume a $25 million stock repurchase programme. The company had received several enquiries regarding a merger (see Clinica No 930, p 11), but has now concluded that the indicated price ranges were insufficient. The Santa Barbara, California company had suspended the stock repurchase programme, which was authorised in September, pending the outcome of the evaluation process.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT075500

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel